“showed a trend”

These post-hoc comparisons also showed a trend that Remember trials were associated with increased frequency of subsequent information-seeking relative to Unfamiliar trials, p = 0.07.

Methotrexate use showed a trend towards a lower IMT value ( p = 0.07).

Analysis of the data by original therapy assignment showed a trend toward improvement in 4-year DFS after treatment with exemestane compared with placebo (relative risk [RR] = 0.68; P = 0.07).

Presence of a DNMT3A mutation was significantly associated with achievement of CR ( P = 0.045); accordingly, patients with co-mutations in genes in the DNA methylation functional category showed a trend toward attainment of CR ( P = 0.07) ( Fig. 2 ).

The Shannon diversity index showed a trend towards an increased bacterial diversity in the non-secretor individuals (p = 0.07).

The increment in the prevalence of overweight were not significant in women; however, results showed a trend ( P = 0.07).

Patients who underwent an allograft showed a trend towards a higher transplant-related mortality, 16% versus 5%, p=0.07, and no difference in overall and event-free survivals.

There was no difference in the overall response rate between the 9 or 18 μg/kg/day cohorts; however, a subset analysis of patients with stage IIB disease or higher, showed a trend towards higher response ( P = 0.07).

The RS group showed a trend toward a shorter postoperative stay ( p = 0.07).

Concomitant use of cyclophosphamide significantly increased the risk of cardiac dysfunction ( P = 0.048), while low BMI (<20 kg/m 2 ) and preexisting cardiac disease showed a trend towards increased risk of cardiac dysfunction ( P = 0.07 for both).

The same plot of the for the sulcal depth measurements showed a trend that approach statistical significance ( r = −0.60; p = 0.07), however, it was negative with higher heritability values observed for structures with smaller rates of change (Figure 5 , bottom).

Indeed, Rb ∆K7 MEFs were significantly more resistant to GW8510 ( P = 0.008) and showed a trend toward significant resistance to a pan‐CDK inhibitor, AT‐751, which targets CDK2, as well as CDK1, CDK4, CDK6, and CDK5 ( P = 0.07; Fig 3B ).

In these subjects the associations between ppRV and these SNPs showed a trend toward significance only for S1 (mean ppRV = 132.1 for the common genotype, n = 379, and ppRV = 118.4 for the less common genotypes, n = 74, p value < 0.07).

In contrast, the systemic treatment group exhibited significant bone loss compared to controls ( p = 0.032) but showed a trend toward significant ( p = 0.07) partial restoration of bone support.

This polymorphism also showed a trend toward being associated with AML risk under the dominant model ( p = 0.07).

Serum triglyceride levels showed a trend toward a main effect of E2 treatment by two‐way ANOVA ( p = 0.07; Figure 5F), with lower levels in both E2‐treated groups compared with their respective vehicle controls.

In the FD task, no significant differences were observed in the right-hand, left-hand, or both-hands subtasks (p = 0.66–0.89, d = -0.12 to 0.04), whereas the assembly subtask showed a trend toward lower performance in the CNNP group (p = 0.07, d = –0.51).

Older age showed a trend toward increased non-adherence ( p = 0.07), while gender, subspecialty, fellowship status, workplace, and procedure volume were not associated with prescribing practices.

conducted a multicenter retrospective study of 130 newly diagnosed older AML patients receiving HMA/venetoclax and found that while pre-existing CKD showed a trend toward lower overall response rates (OR: 0.5; p=0.07), it did not significantly affect overall survival; however, acute kidney injury during treatment was an independent prognostic factor for inferior overall survival (HR: 1.86; p=0.01) [ 15 ].

STZ administration showed a trend toward reduced mature BDNF content compared with the SHAM group ( p = 0.07), whereas combined VitD 3 and DMF treatment significantly increased mature BDNF content compared with the STZ group.

If patients with MGUS and indeterminate SPEP results were considered together, 15% of patients with Bartonella IEGN had serum protein electrophoresis alteration raising the possibility of a monoclonal protein, which showed a trend toward enrichment ( P = 0.07) compared with culture+ IEGN.

Additionally, in patients with hormone receptor positive disease, TILs as a continuous variable showed a trend to a positive association with pCR (adjusted Odds Ratio per 10% increase in TILs 1.15, 95% CI 0.99–1.34, p = 0.070) and IDFS (adjusted Hazard Ratio per 10% increase in TILs 0.71, 95% CI 0.50–1.01, p = 0.058).

Patients who developed thyroid irAEs showed a trend toward improved OS (log-rank p = 0.07; HR 0.45, 95% CI 0.19–1.08), which reached statistical significance after adjustment for predefined confounders (HR 0.40, 95% CI 0.17–0.98; p = 0.045).

Grafts with a GRWR < 0.8 showed a trend toward higher proportional growth (137% ± 55% vs. 110% ± 41%; p = 0.07 for parametric, p = 0.04 for non-parametric).

While there was no significant difference in reducing overall disability compared to no thrombolysis, the effect estimate showed a trend favoring Tenecteplase (gOR 1.28, CI 0.98–1.67; p = 0.07; I 2 = 0%) ( Figure 3 ). 4.